SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
17434847
Source:
http://linkedlifedata.com/resource/pubmed/id/17434847
Search
Subject
(
59
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0030705
,
umls-concept:C0205210
,
umls-concept:C0205466
,
umls-concept:C0205470
,
umls-concept:C0542559
,
umls-concept:C1963724
pubmed:issue
1
pubmed:dateCreated
2007-4-16
pubmed:abstractText
To evaluate the effectiveness and safety of enfuvirtide-based therapy in treatment-experienced patients in a clinical setting.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/100936377
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Retroviral Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/HIV Envelope Protein gp41
,
http://linkedlifedata.com/resource/pubmed/chemical/HIV Fusion Inhibitors
,
http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments
,
http://linkedlifedata.com/resource/pubmed/chemical/enfuvirtide
pubmed:status
MEDLINE
pubmed:issn
1528-4336
pubmed:author
pubmed-author:AntoniouTT
,
pubmed-author:DiongCC
,
pubmed-author:FletcherDD
,
pubmed-author:HalpennyRR
,
pubmed-author:KovacsCC
,
pubmed-author:LoutfyM RMR
,
pubmed-author:RaboudJ MJM
,
pubmed-author:ShenSS
,
pubmed-author:VlaicuMM
pubmed:issnType
Print
pubmed:volume
8
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
36-44
pubmed:meshHeading
pubmed-meshheading:17434847-Adult
,
pubmed-meshheading:17434847-Anti-Retroviral Agents
,
pubmed-meshheading:17434847-CD4 Lymphocyte Count
,
pubmed-meshheading:17434847-Canada
,
pubmed-meshheading:17434847-Cohort Studies
,
pubmed-meshheading:17434847-Drug Therapy, Combination
,
pubmed-meshheading:17434847-Endpoint Determination
,
pubmed-meshheading:17434847-Female
,
pubmed-meshheading:17434847-HIV
,
pubmed-meshheading:17434847-HIV Envelope Protein gp41
,
pubmed-meshheading:17434847-HIV Fusion Inhibitors
,
pubmed-meshheading:17434847-HIV Infections
,
pubmed-meshheading:17434847-Humans
,
pubmed-meshheading:17434847-Injections
,
pubmed-meshheading:17434847-Male
,
pubmed-meshheading:17434847-Middle Aged
,
pubmed-meshheading:17434847-Peptide Fragments
,
pubmed-meshheading:17434847-Retrospective Studies
,
pubmed-meshheading:17434847-Time Factors
,
pubmed-meshheading:17434847-Treatment Outcome
,
pubmed-meshheading:17434847-Viral Load
pubmed:articleTitle
Virologic and immunologic impact and durability of enfuvirtide-based antiretroviral therapy in HIV-infected treatment-experienced patients in a clinical setting.
pubmed:affiliation
Department of Medicine, University of Toronto, Toronto, Ontario Maple Leaf Medical Clinical, Toronto, Ontario, Canada. mona.loutfy@wchospital.ca
pubmed:publicationType
Journal Article
,
Research Support, Non-U.S. Gov't